These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1114 related articles for article (PubMed ID: 16938520)
1. Bone marrow infiltration pattern in B-cell chronic lymphocytic leukemia is related to immunoglobulin heavy-chain variable region mutation status and expression of 70-kd zeta-associated protein (ZAP-70). Schade U; Bock O; Vornhusen S; Jäger A; Büsche G; Lehmann U; Kreipe H Hum Pathol; 2006 Sep; 37(9):1153-61. PubMed ID: 16938520 [TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of flow cytometric techniques in assessment of ZAP-70 expression in relation to IgVH mutational status in chronic lymphocytic leukemia. Chen YH; Peterson LC; Dittmann D; Evens A; Rosen S; Khoong A; Shankey TV; Forman M; Gupta R; Goolsby CL Am J Clin Pathol; 2007 Feb; 127(2):182-91. PubMed ID: 17210531 [TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of ZAP-70 expression and Ig VH mutational status in B-cell chronic lymphocytic leukemia. Muñoz L; Lasa A; Carricondo MT; Hernández C; Ubeda J; Nomdedéu JF Cytometry B Clin Cytom; 2007 Mar; 72(2):96-102. PubMed ID: 17051526 [TBL] [Abstract][Full Text] [Related]
5. ZAP-70 expression, as detected by immunohistochemistry on bone marrow biopsies from early-phase CLL patients, is a strong adverse prognostic factor. Zanotti R; Ambrosetti A; Lestani M; Ghia P; Pattaro C; Remo A; Zanetti F; Stella S; Perbellini O; Prato G; Guida G; Caligaris-Cappio F; Menestrina F; Pizzolo G; Chilosi M Leukemia; 2007 Jan; 21(1):102-9. PubMed ID: 17082778 [TBL] [Abstract][Full Text] [Related]
6. Zap-70 and CD38 as predictors of IgVH mutation in CLL. Cruse JM; Lewis RE; Webb RN; Sanders CM; Suggs JL Exp Mol Pathol; 2007 Dec; 83(3):459-61. PubMed ID: 17931624 [TBL] [Abstract][Full Text] [Related]
7. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. Crespo M; Bosch F; Villamor N; Bellosillo B; Colomer D; Rozman M; Marcé S; López-Guillermo A; Campo E; Montserrat E N Engl J Med; 2003 May; 348(18):1764-75. PubMed ID: 12724482 [TBL] [Abstract][Full Text] [Related]
8. B cell chronic lymphocytic leukaemia/small lymphocytic lymphoma: role of ZAP70 determination on bone marrow biopsy specimens. Sabattini E; Orduz R; Campidelli C; Zinzani PL; Callea V; Zupo S; Cutrona G; Morabito F; Ferrarini M; Pileri S J Clin Pathol; 2007 Jun; 60(6):627-32. PubMed ID: 16916999 [TBL] [Abstract][Full Text] [Related]
9. IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution. Mao Z; Quintanilla-Martinez L; Raffeld M; Richter M; Krugmann J; Burek C; Hartmann E; Rudiger T; Jaffe ES; Müller-Hermelink HK; Ott G; Fend F; Rosenwald A Am J Surg Pathol; 2007 Oct; 31(10):1605-14. PubMed ID: 17895764 [TBL] [Abstract][Full Text] [Related]
10. miRNA analysis in B-cell chronic lymphocytic leukaemia: proliferation centres characterized by low miR-150 and high BIC/miR-155 expression. Wang M; Tan LP; Dijkstra MK; van Lom K; Robertus JL; Harms G; Blokzijl T; Kooistra K; van T'veer MB; Rosati S; Visser L; Jongen-Lavrencic M; Kluin PM; van den Berg A J Pathol; 2008 May; 215(1):13-20. PubMed ID: 18348159 [TBL] [Abstract][Full Text] [Related]
11. Zeta-chain associated protein 70 and CD38 combined predict the time to first treatment in patients with chronic lymphocytic leukemia. Del Giudice I; Morilla A; Osuji N; Matutes E; Morilla R; Burford A; Maravelaki S; Owusu-Ankomah K; Swansbury J; A'Hern R; Brito-Babapulle V; Catovsky D Cancer; 2005 Nov; 104(10):2124-32. PubMed ID: 16211545 [TBL] [Abstract][Full Text] [Related]
12. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Wiestner A; Rosenwald A; Barry TS; Wright G; Davis RE; Henrickson SE; Zhao H; Ibbotson RE; Orchard JA; Davis Z; Stetler-Stevenson M; Raffeld M; Arthur DC; Marti GE; Wilson WH; Hamblin TJ; Oscier DG; Staudt LM Blood; 2003 Jun; 101(12):4944-51. PubMed ID: 12595313 [TBL] [Abstract][Full Text] [Related]
13. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. Rassenti LZ; Huynh L; Toy TL; Chen L; Keating MJ; Gribben JG; Neuberg DS; Flinn IW; Rai KR; Byrd JC; Kay NE; Greaves A; Weiss A; Kipps TJ N Engl J Med; 2004 Aug; 351(9):893-901. PubMed ID: 15329427 [TBL] [Abstract][Full Text] [Related]
14. ZAP-70 expression in B-cell chronic lymphocytic leukemia: evaluation by external (isotypic) or internal (T/NK cells) controls and correlation with IgV(H) mutations. Zucchetto A; Bomben R; Bo MD; Nanni P; Bulian P; Rossi FM; Del Principe MI; Santini S; Del Poeta G; Degan M; Gattei V Cytometry B Clin Cytom; 2006 Jul; 70(4):284-92. PubMed ID: 16906587 [TBL] [Abstract][Full Text] [Related]
15. Kolmogorov-Smirnov statistical test for analysis of ZAP-70 expression in B-CLL, compared with quantitative PCR and IgV(H) mutation status. Van Bockstaele F; Janssens A; Piette A; Callewaert F; Pede V; Offner F; Verhasselt B; Philippé J Cytometry B Clin Cytom; 2006 Jul; 70(4):302-8. PubMed ID: 16906582 [TBL] [Abstract][Full Text] [Related]
16. Prognostic relevance of the FAB morphological criteria in chronic lymphocytic leukemia: correlations with IgVH gene mutational status and other prognostic markers. Schwarz J; Mikulenková D; Cermáková M; Polanská V; Michalová K; Marinov I; Campr V; Ransdorfová S; Marková J; Pavlistová L; Brezinová J; Sajdová J; Sponerová D; Volková Z; Benesová K; Cermák J; Vítek A; Cetkovský P Neoplasma; 2006; 53(3):219-25. PubMed ID: 16652191 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of ZAP-70 expression by flow cytometry in chronic lymphocytic leukemia: A multicentric international harmonization process. Letestu R; Rawstron A; Ghia P; Villamor N; Boeckx N; Boettcher S; Buhl AM; Duerig J; Ibbotson R; Kroeber A; Langerak A; Le Garff-Tavernier M; Mockridge I; Morilla A; Padmore R; Rassenti L; Ritgen M; Shehata M; Smolewski P; Staib P; Ticchioni M; Walker C; Ajchenbaum-Cymbalista F Cytometry B Clin Cytom; 2006 Jul; 70(4):309-14. PubMed ID: 16906588 [TBL] [Abstract][Full Text] [Related]
18. Different gene expression in immunoglobulin-mutated and immunoglobulin-unmutated forms of chronic lymphocytic leukemia. Ferrer A; Ollila J; Tobin G; Nagy B; Thunberg U; Aalto Y; Vihinen M; Vilpo J; Rosenquist R; Knuutila S Cancer Genet Cytogenet; 2004 Aug; 153(1):69-72. PubMed ID: 15325098 [TBL] [Abstract][Full Text] [Related]
19. Comparison of bone marrow and peripheral blood ZAP-70 status examined by flow cytometric immunophenotyping in patients with chronic lymphocytic leukemia. Sheridan R; Mounajjed T; Ehrmann DE; Hurtubise PE; Schrager JA Cytometry B Clin Cytom; 2006 Jul; 70(4):320-1. PubMed ID: 16906578 [TBL] [Abstract][Full Text] [Related]
20. Variations in the detection of ZAP-70 in chronic lymphocytic leukemia: Comparison with IgV(H) mutation analysis. Sheikholeslami MR; Jilani I; Keating M; Uyeji J; Chen K; Kantarjian H; O'Brien S; Giles F; Albitar M Cytometry B Clin Cytom; 2006 Jul; 70(4):270-5. PubMed ID: 16906585 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]